Remarkable response of BRAF ^V600E-mutated metastatic pancreatic cancer to BRAF/MEK inhibition: a case report

Gastroenterol Rep (Oxf). 2021 Sep 13:10:goab031. doi: 10.1093/gastro/goab031. eCollection 2022.

Authors

Hong-Shuai Li¹, Ke Yang², Yan Wang¹

Affiliations

¹ Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
² Department of Medical Oncology, Cancer Hospital of HuanXing, Chaoyang District, Beijing, P. R. China.

No abstract available